ClinicalTrials.Veeva

Menu

Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Withdrawn

Conditions

Wasp Venom Allergic Patients

Treatments

Other: Taking blood samples

Study type

Observational

Funder types

Other

Identifiers

NCT00794287
ZU-AgNT-004

Details and patient eligibility

About

To determine which subclass of IgG in the serum of patients undergoing SIT against wasp venom is able to neutralize the allergen, and therefore to prevent a positive CAST

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • male and female patient with allergy to wasp venom grade III and IV according to H.L. Müller
  • 18-75 years
  • planned SIT against wasp venom or finished 5 years SIT against wsp venom (10/10)

Exclusion criteria

  • oral corticosteroids
  • chromogycin
  • ketotifen
  • immunosuppressive drugs within the last 2 years

Trial design

0 participants in 2 patient groups

1
Description:
Hymenoptera allergic patients before allergen specific immunotherapy
Treatment:
Other: Taking blood samples
2
Description:
Hymenoptera allergic patients after allergen specific immunotherapy
Treatment:
Other: Taking blood samples

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems